CH598235A5 - - Google Patents

Info

Publication number
CH598235A5
CH598235A5 CH1809673A CH1809673A CH598235A5 CH 598235 A5 CH598235 A5 CH 598235A5 CH 1809673 A CH1809673 A CH 1809673A CH 1809673 A CH1809673 A CH 1809673A CH 598235 A5 CH598235 A5 CH 598235A5
Authority
CH
Switzerland
Application number
CH1809673A
Inventor
Gunter Metz
Manfred Specker
Original Assignee
Merckle Ludwig Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Ludwig Kg filed Critical Merckle Ludwig Kg
Publication of CH598235A5 publication Critical patent/CH598235A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1809673A 1972-12-22 1973-12-21 CH598235A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722263110 DE2263110B2 (de) 1972-12-22 1972-12-22 2-Amino-4-phenyläthylamino-6-phenoxymethyl-1 ^-triazine und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
CH598235A5 true CH598235A5 (xx) 1978-04-28

Family

ID=5865287

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1809673A CH598235A5 (xx) 1972-12-22 1973-12-21

Country Status (4)

Country Link
AT (1) AT328459B (xx)
CH (1) CH598235A5 (xx)
DE (1) DE2263110B2 (xx)
GB (1) GB1384684A (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005030735A1 (en) * 2003-09-25 2005-04-07 Ranbaxy Laboratories Limited Triazines derivatives as cell adhesion inhibitors

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3950802A (en) * 2000-12-07 2002-06-18 Cv Therapeutics Inc Abca-1 elevating compounds
JP5491871B2 (ja) * 2007-02-28 2014-05-14 アドビナス セラピュティックス プライベート リミテッド グルコキナーゼ活性化因子としての２，２，２−三置換アセトアミド誘導体、その方法及び薬学的応用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005030735A1 (en) * 2003-09-25 2005-04-07 Ranbaxy Laboratories Limited Triazines derivatives as cell adhesion inhibitors

Also Published As

Publication number Publication date
AT328459B (de) 1976-03-25
DE2263110C3 (xx) 1980-09-18
DE2263110B2 (de) 1980-01-31
GB1384684A (en) 1975-02-19
ATA1076673A (de) 1975-06-15
DE2263110A1 (de) 1974-07-11

Similar Documents

Publication Publication Date Title
FR2193608A1 (xx)
FR2178698A5 (xx)
JPS492698A (xx)
CH566059A5 (xx)
CH576156A5 (xx)
BG18207A1 (xx)
BG17989A1 (xx)
BG17986A1 (xx)
BG21811A1 (xx)
BG25905A1 (xx)
CH1722773A4 (xx)
CH559379A5 (xx)
CH559388A5 (xx)
CH560333A5 (xx)
CH561417A5 (xx)
CH562310A5 (xx)
CH563928A5 (xx)
CH590932A5 (xx)
CH598235A5 (xx)
CH564228A (xx)
BG20341A3 (xx)
CH565539A5 (xx)
CH565572A5 (xx)
CH573138B5 (xx)
CH566101A5 (xx)

Legal Events

Date Code Title Description
PL Patent ceased